Albert G. White III Sells 114,992 Shares of The Cooper Companies, Inc. (NASDAQ:COO) Stock

The Cooper Companies, Inc. (NASDAQ:COO) CEO Albert G. White III sold 114,992 shares of the firm’s stock in a transaction that occurred on Thursday, September 19th. The shares were sold at an average price of $110.53, for a total value of $12,710,065.76. Following the completion of the transaction, the chief executive officer now owns 165,273 shares of the company’s stock, valued at approximately $18,267,624.69. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Cooper Companies Stock Down 0.5 %

Cooper Companies stock opened at $110.49 on Monday. The firm has a market cap of $22.00 billion, a price-to-earnings ratio of 64.99, a PEG ratio of 2.60 and a beta of 0.98. The stock has a fifty day simple moving average of $97.93 and a two-hundred day simple moving average of $95.45. The Cooper Companies, Inc. has a 12 month low of $75.93 and a 12 month high of $112.38. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Wednesday, August 28th. The medical device company reported $0.96 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. The business had revenue of $1 billion during the quarter, compared to analyst estimates of $997.30 million. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The company’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter last year, the company earned $0.84 EPS. Equities analysts predict that The Cooper Companies, Inc. will post 3.66 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

COO has been the subject of a number of research analyst reports. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research note on Thursday, August 29th. Piper Sandler raised their target price on Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Wells Fargo & Company raised their target price on Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Robert W. Baird raised their price objective on Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a research report on Thursday, August 29th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and set a $115.00 price objective (up previously from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Four equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $115.00.

Institutional Trading of Cooper Companies

A number of institutional investors and hedge funds have recently modified their holdings of the business. Franklin Resources Inc. grew its holdings in shares of Cooper Companies by 1.2% in the fourth quarter. Franklin Resources Inc. now owns 3,401 shares of the medical device company’s stock worth $1,287,000 after acquiring an additional 41 shares during the period. LRI Investments LLC grew its holdings in shares of Cooper Companies by 4.5% in the second quarter. LRI Investments LLC now owns 2,595 shares of the medical device company’s stock worth $227,000 after acquiring an additional 112 shares during the period. Commonwealth Equity Services LLC lifted its position in Cooper Companies by 0.8% during the second quarter. Commonwealth Equity Services LLC now owns 15,600 shares of the medical device company’s stock valued at $1,362,000 after purchasing an additional 118 shares in the last quarter. First Horizon Advisors Inc. increased its position in Cooper Companies by 4.8% in the second quarter. First Horizon Advisors Inc. now owns 2,709 shares of the medical device company’s stock worth $236,000 after buying an additional 125 shares in the last quarter. Finally, American International Group Inc. increased its position in Cooper Companies by 1.0% in the fourth quarter. American International Group Inc. now owns 13,229 shares of the medical device company’s stock worth $5,006,000 after buying an additional 137 shares in the last quarter. Institutional investors own 24.39% of the company’s stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.